https://www.selleckchem.com/pr....oducts/PHA-793887.ht
nts have an increased postoperative risk for negative complications.Every medical product requires additional study even after regulatory approval. We highlight several lines of enquiry to advance our understanding of COVID19 vaccines post authorization identifying key population segments warranting more study, assessment of efficacy, and of safety data, harmonization of data relating to immune response and developing mechanisms for data and knowledge sharing across countries. We show how innovative trial designs and sources from rea
Like
Comment
Share
